Overview


According to FutureWise analysis the market for Anesthesia Drugs is expected to register a CAGR of 3.80% from 2023-2031.

Anesthesia refers to the use of medications (called anesthetics) to keep an individual from feeling pain during procedures or surgery. Anesthetics temporarily block sensory signals from your nerves at the site of the procedure to the centers of your brain. Different types of anesthesia work in different ways. The type of anesthesia depends on the type of surgery and medical condition. During the anesthesia process, sedatives (which induce sleepiness) and analgesics (to ease the pain) may also be used. Additionally, some anesthetic medications numb certain parts of your body. Other anesthetics numb your brain so you can sleep through more invasive surgical procedures. Doctors may administer anesthetics either through injection or inhalation, depending on the type of anesthetic and the type of medical procedure.

There are two types of anesthesia drugs: local anesthesia drugs and general anesthesia drugs. Local anesthetics, also known as numbing agents, function by blocking the transfer of NERVE IMPULSEs that transmit pain signals. Local anesthetics can be administered through injection or sprayed in a small area to create a localized area without sensation or injected next to major nerves to decrease the sensation to an entire limb. For procedures involving the placement of a camera, such as ENT (an ear, nose, and throat) office procedure or upper gastrointestinal endoscopy (EGD), substances such as benzocaine spray or lidocaine ointment are used to numb the mouth and throat. Lidocaine, mepivacaine, bupivacaine (Marcaine®), and ropivacaine for injections in surgical areas or regional anesthesia through nerve blocks. General anesthetics are drugs that induce and maintain a state of unconsciousness. They cause anterograde amnesia, preventing patients from recollecting events after administration administration. This class of medications creates amnesia for surgical procedures. These can be given either by intravenous injection or inhaled as a gas.

FutureWise Market Research has published a report that provides an insightful analysis anesthesia drugs market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. According to the analysis conducted by FutureWise research analysts, anesthesia drugs market is estimated to register a considerable growth rate over the forecast period. This report lists the market segments and potential prospects available across this industry, in addition providing crucial information on the total valuation currently held by the industry. Moreover, this report will assist key management individuals in an organisation to enhance their decisions pertaining to business expansion as well as strategic changes for increasing customer base.

  • AbbVie Inc.
  • Apsen Pharmacare Holdings Limited
  • Baxter International Inc.
  • B. Braun Melsungen AG
  • Fresenius SECo. KGaA
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Limited
  • Dr. Reddy's Laboratories
  • Abbott Laboratories Inc.
  • Novartis AG
  • Eisai Inc.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent Developments in Anesthesia Drugs Market:

  • In January 2022, Laboratoires Théa SAS (Théa) entered into an agreement to purchase seven branded ophthalmic products, including Akten (lidocaine HCl ophthalmic gel), an anesthesia drug, from Akorn Operating Company LLC. This strategic move will enable Théa to expand its portfolio with a range of Akorn-branded products, including this local anesthetic indicated for ocular surface anesthesia during ophthalmologic procedures.

The increasing prevalence of surgical procedures, including both elective and essential treatments, may increase the demand for anesthesia drugs market forward. With the global population witnessing continuous growth and aging trends, the demand for surgical procedure is expected to increase. This shift, associated with the increasing prevalence of chronic health conditions, and the need for surgeries, therefore making a sustained demand for anesthesia drugs. Also, the growing geriatric population presents a substantial driver in the anesthesia drugs market. As individuals grow older, the possibility of requiring surgical treatment increases due to age-related health issues and the need for various medical procedures. With longings and advancements in healthcare, a growing cohort of senior individuals are likely to undergo surgeries. Consequently, this demographic change significantly boosts the demand for anesthesia drugs, emphasizing their vital role in ensuring safe and effective surgical experiences for older patients globally. However, administering anesthetics drugs presents a possible risk of toxic and adverse side effects, which may vary based on the type and drug dosage. These effects may include respiratory depression, cardiovascular instability, allergic reactions, and, in rare circumstances, even neurotoxicity. Moreover, the blood-brain barrier (BBB) poses a significant restrain in acquiring accurate control over the anesthetic's effects, as it limits the passage of many drugs into the central nervous system. This necessitates utilizing higher doses or specialized formulations, which may increase the risk of adverse effects. Therefore, hindering the growth of the anesthesia drugs market.

By Drug Type

  • General Anesthesia Drugs
    • Propofol
    • Sevoflurane
    • Desflurane
    • Dexmedetomidine
    • Remifentanil
    • Midazolam
    • Other General Anesthesia Drugs
  • Local Anesthesia Drugs
    • Bupivacaine
    • Ropivacaine
    • Lidocaine
    • Chloroprocaine
    • Prilocaine
    • Benzocaine
    • Other Local Anesthesia Drugs

By Route of Administration

  • Inhalation
  • Injection
  • Other Routes of Administration

By Application

  • General Surgery
  • Plastic Surgery
  • Cosmetic Surgery
  • Dental Surgery
  • Other Applications

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of region will also be provided in the final version of this market which is based on conclusion of primary interviews and secondary data point gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered highest share in the market in 2022. This is driven by the rising aging population with increasing chronic conditions, increasing the number of surgeries, advancements in anesthesia technologies, use of anesthetics during the surgical procedure, and increasing incidents of traumatic injuries and accidents requiring surgical procedures in the region, which is likely to propel the target market. Moreover, novel anesthesia drugs are being developed in the country, which is anticipated to drive market growth. For instance, in December 2021, Hikma Pharmaceuticals PLC (Hikma) introduced Bupivacaine HCl Injection USP, an anesthesia drug, through its United States affiliate, Hikma Pharmaceuticals USA Inc. The company released variants at concentrations of 0.25%, 0.5%, and 0.75% in both 10 milliliter and 30 milliliter doses. Therefore, the above-mentioned factors are expected to boost the market growth over the forecast period in the area.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Anesthesia Drugs Market By Drug Type, By Route of Administration, By Application and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Global Anesthesia Drugs Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Anesthesia Drugs Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Anesthesia Drugs Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Anesthesia Drugs Market, By Drug Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. General Anesthesia Drugs
         1.1. Propofol
         1.2. Sevoflurane
         1.3. Desflurane
         1.4. Dexmedetomidine
         1.5. Remifentanil
         1.6. Midazolam
         1.7. Other General Anesthesia Drugs
        2. Local Anesthesia Drugs
         2.1. Bupivacaine
         2.2. Ropivacaine
         2.3. Lidocaine
         2.4. Chloroprocaine
         2.5. Prilocaine
         2.6. Benzocaine
         2.7. Other Local Anesthesia Drugs

  • 8.   Global Anesthesia Drugs Market, By Route of Administration Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Inhalation
        2. Injection
        3. Other Routes of Administration

  • 9.   Global Anesthesia Drugs Market, By Application Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. General Surgery
        2. Plastic Surgery
        3. Cosmetic Surgery
        4. Dental Surgery
        5. Others Applications

  • 10.   North America Anesthesia Drugs Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Anesthesia Drugs Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Anesthesia Drugs Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Anesthesia Drugs Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. AbbVie Inc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Apsen Pharmacare Holdings Limited
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Baxter International Inc.
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. B. Braun Melsungen AG
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Fresenius SECo. KGaA
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. Pfizer Inc.
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Teva Pharmaceutical Industries Limited
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Dr. Reddy's Laboratories
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Abbott Laboratories Inc.
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10.Novartis AG
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11.Eisai Inc.
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client

Related Market

Anesthesia Monitor Market

Read More

Local Anesthesia Drugs Market

Read More

Anesthesia Devices Market

Read More

General Anesthesia Drugs Market

Read More

Ophthalmic Anesthetic Drugs Market

Read More
Partner

Our Clients